Ποια είναι η τιμή για D. Western Therapeutics Institute, Inc. (4576)

Η τιμή για D. Western Therapeutics Institute, Inc. (4576) είναι $0.56109583

Ποια είναι η κεφαλαιοποίηση αγοράς για D. Western Therapeutics Institute, Inc. (4576)

Η κεφαλαιοποίηση αγοράς για D. Western Therapeutics Institute, Inc. (4576) είναι $32.25M

D. Western Therapeutics Institute, Inc. (4576) Τιμή και Κεφαλαιοποίηση Αγοράς

D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.

Η τιμή για 4576	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$92,227.91 $32.25M	NVDA	$5.301T	+16,437,004.44%
$80,623.02 $32.25M	AAPL	$4.634T	+14,368,749.39%
$72,082.24 $32.25M	GOOG	$4.143T	+12,846,590.04%
$62,450.21 $32.25M	MSFT	$3.589T	+11,129,944.19%
$49,707.03 $32.25M	AMZN	$2.857T	+8,858,819.56%

Η τιμή για 4576

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$92,227.91 $32.25M